Functional Role of Resveratrol in Inducing Apoptosis in Breast Cancer Subtypes via Inhibition of Intracellular Fatty

Ping Li1,2, Yan Liang3, Xiaofeng Ma1

  • 1University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.

PubMed

Insights

Resveratrol inhibits fatty acid synthase (FASN) in breast cancer cells, reducing fatty acid levels and promoting cancer cell death. This suggests resveratrol is a potential therapeutic agent for breast cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Fatty acid synthase (FASN) is overexpressed in human breast cancer, presenting a therapeutic target.
  • Resveratrol demonstrates in vitro inhibition of FASN activity via reversible and irreversible mechanisms.

Purpose of the Study:

  • To investigate resveratrol's effect on FASN activity, expression, and breast cancer cell viability.
  • To explore the role of FASN inhibition in resveratrol-induced apoptosis and signaling pathway modulation.

Main Methods:

  • Treatment of breast cancer cell lines (SK-BR-3, MCF-7, MDA-MB-231) with resveratrol.
  • Fatty acid synthase (FASN) knockdown using small interfering RNA (siRNA).
  • Assessment of cell viability, apoptosis markers (PARP cleavage, Bcl-2 family proteins), and signaling pathways (FAK, AKT, ERK1/2).

Main Results:

  • Resveratrol inhibited FASN activity and downregulated its expression, reducing intracellular fatty acids across breast cancer subtypes.
  • FASN knockdown potentiated resveratrol-induced cytotoxicity and apoptosis.
  • Resveratrol suppressed cell viability, induced apoptosis, and inhibited FAK, AKT, and ERK1/2 signaling pathways.

Conclusions:

  • Resveratrol effectively inhibits FASN in various breast cancer cells, leading to reduced proliferation and induced apoptosis.
  • Combined FASN inhibition and resveratrol treatment enhance anti-cancer effects.
  • Resveratrol shows promise as an anti-cancer therapeutic by targeting FASN and associated signaling pathways in breast cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K